February 04, 2021 at 10:20PM Rare Disease Therapy Development and Access Remain Top FDA Priorities During COVID-19

FDA’s work to advance treatments for rare diseases and helping ensure continuity of care for people with rare diseases remain top priorities during COVID-19.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2MPMf5O